|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.040 CNY | -0.79% |
|
-6.15% | -31.61% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.18B 764M 668M 618M 577M 1.08B 72.24B 1.09B 7.34B 2.86B 35.52B 2.87B 2.81B 123B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.04B 596M 521M 482M 450M 844M 56.32B 850M 5.72B 2.23B 27.69B 2.24B 2.19B 96.19B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.41% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.79% | ||
| 1 week | -6.15% | ||
| Current month | -14.29% | ||
| 1 month | -16.97% | ||
| 3 months | -13.55% | ||
| 6 months | -35.96% | ||
| Current year | -31.61% |
| 1 week | 4.81 |  | 5.31 |
| 1 month | 4.81 | | 6.14 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 23/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 10/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-04 | Buy | Director | 100 | 0.0000% | ||
| 28/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 27/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -6.15% | -28.51% | -48.78% | 771M | |
| +0.51% | -2.16% | +43.38% | +141.43% | 980B | |
| +0.92% | -2.21% | +52.29% | +39.14% | 550B | |
| +5.97% | +3.76% | +25.12% | +67.32% | 382B | |
| -0.06% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.42% | +0.68% | +27.54% | +14.57% | 272B | |
| +1.67% | +0.05% | +26.50% | +33.56% | 268B | |
| +2.39% | +5.02% | -33.44% | -44.76% | 199B | |
| +1.75% | -2.01% | +26.08% | +49.57% | 182B | |
| +0.48% | +0.23% | +17.32% | +59.49% | 154B | |
| Average | +1.35% | -2.94% | +17.96% | +32.83% | 330.31B | |
| Weighted average by Cap. | +1.44% | -3.50% | +31.35% | +64.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.5M 85.2M 78.81M 73.55M 138M 9.21B 139M 936M 364M 4.53B 366M 358M 15.74B | 624M 92.07M 80.45M 74.42M 69.46M 130M 8.7B 131M 884M 344M 4.28B 346M 338M 14.86B |
| Net income | -74.07M -10.93M -9.55M -8.84M -8.25M -15.49M -1.03B -15.6M -105M -40.86M -508M -41.05M -40.16M -1.76B | -347M -51.26M -44.79M -41.43M -38.67M -72.59M -4.84B -73.13M -492M -192M -2.38B -192M -188M -8.27B |
| Net Debt | -1.98B -293M -256M -237M -221M -414M -27.66B -417M -2.81B -1.09B -13.6B -1.1B -1.07B -47.24B | -1.14B -168M -147M -136M -127M -239M -15.92B -240M -1.62B -630M -7.83B -633M -619M -27.2B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/06/26 | 5.040 ¥ | -0.79% | 22,848,440 |
| 18/06/26 | 5.080 ¥ | +0.99% | 19,168,410 |
| 17/06/26 | 5.030 ¥ | -2.71% | 20,344,360 |
| 16/06/26 | 5.170 ¥ | -2.64% | 22,337,080 |
| 15/06/26 | 5.310 ¥ | -1.12% | 21,922,660 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
